本页面由Tiger Fintech (Singapore) Pte. Ltd.提供服务

OnKure Therapeutics, Inc.

2.44
+0.07002.95%
成交量:1.51万
成交额:3.66万
市值:3,301.31万
市盈率:-0.41
高:2.51
开:2.40
低:2.31
收:2.37
52周最高:190.00
52周最低:1.70
股本:1,353.00万
流通股本:580.82万
量比:0.29
换手率:0.26%
股息:- -
股息率:- -
每股收益(TTM):-6.0174
每股收益(LYR):-15.2805
净资产收益率:-142.90%
总资产收益率:-70.95%
市净率:0.42
市盈率(LYR):-0.16

数据加载中...

2025/08/13

季度报告

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
2025/08/13

重要事件披露

Form 8-K - Current report
2025/06/26

重要事件披露

Form 8-K - Current report
2025/05/28

重要事件披露

Form 8-K - Current report
2025/05/06

季度报告

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
2025/05/06

重要事件披露

Form 8-K - Current report
2025/03/10

重要事件披露

Form 8-K - Current report
2025/03/10

员工持股计划

Form S-8 - Securities to be offered to employees in employee benefit plans
2025/03/10

年度报告

Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]
2024/12/10

重要事件披露

Form 8-K - Current report
2024/12/09

员工持股计划

Form S-8 - Securities to be offered to employees in employee benefit plans
2024/11/15

超过5%披露

Form SC 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
2024/11/14

超过5%披露

Form SC 13G - Statement of Beneficial Ownership by Certain Investors
2024/11/08

重要事件披露

Form 8-K - Current report
2024/11/08

季度报告

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
2024/10/28

SEC问询函

Form CORRESP - Correspondence
2024/10/28

超过5%披露

Form SC 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
2024/10/23

招股说明书

Form S-1 - General form for registration of securities under the Securities Act of 1933
2024/10/23

超过5%披露

Form SC 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
2024/10/16

超过5%披露

Form SC 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]